Skip to main content

Table 1 Characteristics of the investigated patients groups

From: Phase dependent hypothalamic activation following trigeminal input in cluster headache

 AgeSexYears of cluster headacheNumber of patients taking prophylactic medicationMedication taken
Active Cluster Headache50,083333312 m, 4 f13,203,1259Verapamil (2), Verapamil+Topiramate (1), Lithium (2), Prednisolon (1), Allegro (1), Verapamil+Allegro (1), Almotriptan (1)
Inactive Cluster Headache45,2,380,95218 m, 3 f14,556Verapamil (3),Topiramate (1), Verapamil + Topiramate (2)
\